Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Human alternative Klotho mRNA is a nonsense-mediated mRNA decay target inefficiently spliced in renal disease
Rik Mencke, … , Henri G. Leuvenink, Jan-Luuk Hillebrands
Rik Mencke, … , Henri G. Leuvenink, Jan-Luuk Hillebrands
Published October 19, 2017
Citation Information: JCI Insight. 2017;2(20):e94375. https://doi.org/10.1172/jci.insight.94375.
View: Text | PDF
Research Article Aging Nephrology

Human alternative Klotho mRNA is a nonsense-mediated mRNA decay target inefficiently spliced in renal disease

  • Text
  • PDF
Abstract

Klotho is a renal protein involved in phosphate homeostasis, which is downregulated in renal disease. It has long been considered an antiaging factor. Two Klotho gene transcripts are thought to encode membrane-bound and secreted Klotho. Indeed, soluble Klotho is detectable in bodily fluids, but the relative contributions of Klotho secretion and of membrane-bound Klotho shedding are unknown. Recent advances in RNA surveillance reveal that premature termination codons, as present in alternative Klotho mRNA (for secreted Klotho), prime mRNAs for degradation by nonsense-mediated mRNA decay (NMD). Disruption of NMD led to accumulation of alternative Klotho mRNA, indicative of normally continuous degradation. RNA IP for NMD core factor UPF1 resulted in enrichment for alternative Klotho mRNA, which was also not associated with polysomes, indicating no active protein translation. Alternative Klotho mRNA transcripts colocalized with some P bodies, where NMD transcripts are degraded. Moreover, we could not detect secreted Klotho in vitro. These results suggest that soluble Klotho is likely cleaved membrane-bound Klotho only. Furthermore, we found that, especially in acute kidney injury, splicing of the 2 mRNA transcripts is dysregulated, which was recapitulated by various noxious stimuli in vitro. This likely constitutes a novel mechanism resulting in the downregulation of membrane-bound Klotho.

Authors

Rik Mencke, Geert Harms, Jill Moser, Matijs van Meurs, Arjan Diepstra, Henri G. Leuvenink, Jan-Luuk Hillebrands

×

Figure 2

Blocking nonsense-mediated mRNA decay, using cycloheximide or by silencing UPF1, results in the accumulation of the alternative Klotho mRNA transcript in HK-2 cells.

Options: View larger image (or click on image) Download as PowerPoint
Blocking nonsense-mediated mRNA decay, using cycloheximide or by silenci...
(A) RT-PCR for the 2 Klotho transcripts in HK-2 cells incubated with 100 μg/ml cycloheximide for 0, 2, 4, or 6 hours, showing accumulation of the alternative Klotho transcript. (B) Densitometric quantification of A, expressed as the ratio of the alternative and membrane-bound Klotho mRNAs (values are provided in Supplemental Table 1). (C) qPCR analysis for both Klotho transcripts, using ΔCt = Ct(alternative Klotho transcript) – Ct(membrane-bound Klotho transcript), which confirms the RT-PCR results. (D) RT-PCR for the 2 Klotho transcripts in HK-2 cells after Upf1 or scrambled siRNA transfection for 48 or 120 hours, showing accumulation of the alternative Klotho transcript after 120 hours. (E) Densitometric quantification of D, expressed as the ratio of the alternative and membrane-bound Klotho mRNAs (values are provided in Supplemental Table 2). (F) qPCR analysis for both Klotho transcripts, using ΔCt = Ct(alternative Klotho transcript) – Ct(membrane-bound Klotho transcript), confirms the RT-PCR results. *P < 0.05, **P < 0.01, ***P < 0.001, as tested by one-way ANOVA with post-hoc Bonferroni correction. All individual data points represent means of 3 independent experiments, performed in triplicate (plotted with mean ± SD).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts